BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25761374)

  • 41. [Ultrasound diagnosis of Charcot-Marie-Tooth disease].
    Noto Y
    Brain Nerve; 2014 Mar; 66(3):237-46. PubMed ID: 24607948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients.
    Tozza S; Bruzzese D; Pisciotta C; Iodice R; Esposito M; Dubbioso R; Ruggiero L; Topa A; Spina E; Santoro L; Manganelli F
    Eur J Neurol; 2018 Feb; 25(2):301-306. PubMed ID: 29053907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultrasound for assessment of diaphragm in ALS.
    Pinto S; Alves P; Pimentel B; Swash M; de Carvalho M
    Clin Neurophysiol; 2016 Jan; 127(1):892-897. PubMed ID: 25971723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of axonal loss in Charcot-Marie-Tooth neuropathies.
    Lawson VH; Gordon Smith A; Bromberg MB
    Exp Neurol; 2003 Dec; 184(2):753-7. PubMed ID: 14769367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of respiratory functions by spirometry and phrenic nerve studies in patients of amyotrophic lateral sclerosis.
    Singh D; Verma R; Garg RK; Singh MK; Shukla R; Verma SK
    J Neurol Sci; 2011 Jul; 306(1-2):76-81. PubMed ID: 21496826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative assessment of sciatic nerve changes in Charcot-Marie-Tooth type 1A patients using magnetic resonance neurography.
    Fortanier E; Ogier AC; Delmont E; Lefebvre MN; Viout P; Guye M; Bendahan D; Attarian S
    Eur J Neurol; 2020 Aug; 27(8):1382-1389. PubMed ID: 32391944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Charcot-Marie-Tooth disease type 1A: Longitudinal change in nerve ultrasound parameters.
    Kojima Y; Noto YI; Tsuji Y; Kitani-Morii F; Shiga K; Mizuno T; Nakagawa M
    Muscle Nerve; 2020 Dec; 62(6):722-727. PubMed ID: 32959396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-related changes in motor unit number estimates in adult patients with Charcot-Marie-Tooth type 1A.
    van Dijk JP; Verhamme C; van Schaik IN; Schelhaas HJ; Mans E; Bour LJ; Stegeman DF; Zwarts MJ
    Eur J Neurol; 2010 Aug; 17(8):1098-104. PubMed ID: 20443982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nine-hole Peg Test and Ten-meter Walk Test for Evaluating Functional Loss in Chinese Charcot-Marie-Tooth Disease.
    Niu HX; Wang RH; Xu HL; Song B; Yang J; Shi CH; Li YS; Zhang BQ; Wang SP; Yong Q; Wang YY; Xu YM
    Chin Med J (Engl); 2017 Aug; 130(15):1773-1778. PubMed ID: 28748848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is overwork weakness relevant in Charcot-Marie-Tooth disease?
    Piscosquito G; Reilly MM; Schenone A; Fabrizi GM; Cavallaro T; Santoro L; Vita G; Quattrone A; Padua L; Gemignani F; Visioli F; Laurà M; Calabrese D; Hughes RA; Radice D; Solari A; Pareyson D;
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1354-8. PubMed ID: 24659795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reliability and validity of the CMT neuropathy score as a measure of disability.
    Shy ME; Blake J; Krajewski K; Fuerst DR; Laura M; Hahn AF; Li J; Lewis RA; Reilly M
    Neurology; 2005 Apr; 64(7):1209-14. PubMed ID: 15824348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A patient of Charcot-Marie-tooth disease with rigid spine and respiratory failure].
    Takamure M; Nakamuro T; Sugie K; Suzumura A; Takayanagi T
    Rinsho Shinkeigaku; 2000 May; 40(5):433-8. PubMed ID: 11002724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative assessment of muscle echogenicity in Charcot-Marie-Tooth disease type 1A by automatic thresholding methods.
    Kitaoji T; Noto YI; Kojima Y; Tsuji Y; Mizuno T; Nakagawa M
    Clin Neurophysiol; 2021 Oct; 132(10):2693-2701. PubMed ID: 34294566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolution of Charcot-Marie-Tooth disease type 1A duplication: a 2-year clinico-electrophysiological and lower-limb muscle MRI longitudinal study.
    Pelayo-Negro AL; Gallardo E; García A; Sánchez-Juan P; Infante J; Berciano J
    J Neurol; 2014 Apr; 261(4):675-85. PubMed ID: 24449066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of muscle strength, balance and functionality of individuals with type 2 Charcot-Marie-Tooth Disease.
    de França Costa IMP; Nunes PS; de Aquino Neves EL; Lima Santos Barreto LC; Garcez CA; Souza CC; Pereira Oliveira PM; Sales Ferreira LA; Brandão Lima VN; de Souza Araújo AA
    Gait Posture; 2018 May; 62():463-467. PubMed ID: 29674285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotype of Charcot-Marie-Tooth disease Type 2.
    Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
    Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: a laser-evoked potential study.
    Pazzaglia C; Vollono C; Ferraro D; Virdis D; Lupi V; Le Pera D; Tonali P; Padua L; Valeriani M
    Pain; 2010 May; 149(2):379-385. PubMed ID: 20334975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with foot and ankle strength in healthy preschool-age children and age-matched cases of Charcot-Marie-Tooth disease type 1A.
    Rose KJ; Burns J; North KN
    J Child Neurol; 2010 Apr; 25(4):463-8. PubMed ID: 19671887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unilateral oculomotor palsy in Charcot-Marie-Tooth disease 1A (CMT 1A).
    Posa A; Emmer A; Kornhuber ME
    Clin Neurol Neurosurg; 2017 Apr; 155():20-21. PubMed ID: 28214652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
    Kulkarni SD; Sayed R; Garg M; Patil VA
    Neuromuscul Disord; 2015 Nov; 25(11):916-9. PubMed ID: 26432165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.